Sort
40,608 grants matching “prostate cancer”
Vitamin D Status and Prostate Cancer
$443,393James C Fleet · Purdue University · R01 · FY2007 · CA
Project 3: Analysis of intrinsic and extrinsic factors that promote prostate neuroendocrine differentiation
$443,326Michael M. Shen · Columbia University Health Sciences · P01 · FY2025 · CA
Cohort Study of Risks for Benign Prostatic Hyperplasia
$443,275Fred Hutchinson Cancer Research Center · R01 · FY2005 · DK
Kidney DNA Adductomics
$443,264Robert J. Turesky · University Of Minnesota · R01 · FY2024 · ES
3-way approach for ED prevention
$443,261Carol Ann Podlasek · University Of Illinois At Chicago · R01 · FY2015 · DK
Nitric Oxide as a Modifier of Oxidative Stress
$443,259David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C
$443,212K Jin Kim · Galaxy Biotech, Llc · R44 · FY2011 · CA
Improving prostate biopsy efficiency: The finasteride challenge test
$443,198Ian M Thompson · University Of Texas Hlth Science Center · R01 · FY2011 · CA
Protein Biomarkers of Cancer Risk in Older Persons
$443,168Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
The Role of YY1 in Castration-Resistant Prostate Cancer
$443,147Ling Cai · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Kidney DNA Adductomics
$443,137Robert J. Turesky · University Of Minnesota · R01 · FY2023 · ES
Informed Decision Making Regarding PSA Screening
$443,094Roshan Bastani · University Of California Los Angeles · R01 · FY2006 · CA
Role of Shh in developmental patterning and growth of digit skeleton
$443,079Susan Mackem · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Kidney DNA Adductomics
$443,010Robert J. Turesky · University Of Minnesota · R01 · FY2022 · ES
MOLECULAR STRUCTURE OF STEROIDS
$442,974Hauptman-Woodward Medical Research Inst · R37 · FY2001 · DK
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach
$442,936Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2024 · CA
Developmental Funds
$442,936Primo N Lara · University Of California At Davis · P30 · FY2020 · CA
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
$442,930Andrew J Armstrong · Duke University · R01 · FY2023 · CA
GONADOTROPIN-RELEASING HORMONE ACTION
$442,927Oregon Health And Science University · R37 · FY2000 · HD
MRI of tumor-infiltrating lymphocytes using MRI-cytometry
$442,824Junzhong Xu · Vanderbilt University Medical Center · R01 · FY2024 · CA
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome
$442,771Andrew J Vickers · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Dynamic, multi-cohort prediction modeling of prostate biopsy outcome
$442,771Andrew J Vickers · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
INVESTIGATING THE MOLECULAR MECHANISMS OF ACQUIRED RESISTANCE TO BET BROMODOMAIN INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER
$442,750Trustees Of The University Of Pennsylvania, The · · FY2017 · Department of the Army
Acoustic Angiography Using Dual-Frequency and Ultrawideband CMUT Arrays
$442,733Omer Oralkan · North Carolina State University Raleigh · R01 · FY2021 · EB
Structure, function, and application of novel antagonists of the intrinsically disordered androgen receptor amino-terminal domain as imaging agents and therapeutics
$442,720Marianne D Sadar · Provincial Health Services Authority · R01 · FY2021 · CA